Correlation Between Vincerx Pharma and Bellerophon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Bellerophon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Bellerophon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Bellerophon Therapeutics, you can compare the effects of market volatilities on Vincerx Pharma and Bellerophon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Bellerophon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Bellerophon Therapeutics.
Diversification Opportunities for Vincerx Pharma and Bellerophon Therapeutics
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Vincerx and Bellerophon is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Bellerophon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellerophon Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Bellerophon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellerophon Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Bellerophon Therapeutics go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Bellerophon Therapeutics
Given the investment horizon of 90 days Vincerx Pharma is expected to generate 10.52 times less return on investment than Bellerophon Therapeutics. But when comparing it to its historical volatility, Vincerx Pharma is 2.17 times less risky than Bellerophon Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Bellerophon Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 93.00 in Bellerophon Therapeutics on September 3, 2024 and sell it today you would lose (22.00) from holding Bellerophon Therapeutics or give up 23.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 30.91% |
| Values | Daily Returns |
Vincerx Pharma vs. Bellerophon Therapeutics
Performance |
| Timeline |
| Vincerx Pharma |
| Bellerophon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vincerx Pharma and Bellerophon Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma and Bellerophon Therapeutics
The main advantage of trading using opposite Vincerx Pharma and Bellerophon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Bellerophon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellerophon Therapeutics will offset losses from the drop in Bellerophon Therapeutics' long position.| Vincerx Pharma vs. Seres Therapeutics | Vincerx Pharma vs. DiaMedica Therapeutics | Vincerx Pharma vs. Lyra Therapeutics | Vincerx Pharma vs. Centessa Pharmaceuticals PLC |
| Bellerophon Therapeutics vs. Bio Path Holdings | Bellerophon Therapeutics vs. Capricor Therapeutics | Bellerophon Therapeutics vs. NextCure | Bellerophon Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |